Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.

Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD
Am J Med. 2005 118 (8): 850-7

PMID: 16084177 · DOI:10.1016/j.amjmed.2005.03.001

MeSH Terms (14)

Aged Aged, 80 and over Cost-Benefit Analysis Enzyme Inhibitors Finasteride Humans Male Markov Chains Middle Aged Models, Econometric Prostatic Neoplasms Quality-Adjusted Life Years Randomized Controlled Trials as Topic United States

Connections (1)

This publication is referenced by other Labnodes entities: